Search for other papers by Thanwa Wongsuk in
Current site
Google Scholar
PubMed
Search for other papers by Siriphan Boonsilp in
Current site
Google Scholar
PubMed
Search for other papers by Potjaman Pumeesat in
Current site
Google Scholar
PubMed
Search for other papers by Anchalee Homkaew in
Current site
Google Scholar
PubMed
Search for other papers by Tanes Sangsri in
Current site
Google Scholar
PubMed
Search for other papers by Piriyaporn Chongtrakool in
Current site
Google Scholar
PubMed
Abstract
The basidiomycetes yeast Trichosporon is widespread in the natural environment, but can cause disease, mainly in immunocompromised patients. However, there have been only few studies about this infection in Thailand. In this study, we characterized 53 Trichosporon spp. isolated from urine samples from patients admitted to a single hospital in Bangkok, Thailand over a one-year period from 2019 to 2020. The strains were identified using colony morphology, microscopy, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and nucleotide sequence analysis of intergenic spacer 1 (IGS1). Fifty-one isolates were Trichosporon asahii, and the remaining isolates were Trichosporon inkin and other Trichosporon species. Three genotypes of IGS1—1, 3, and 7 were observed among T. asahii. The sensitivity of the yeasts to the antifungal drugs amphotericin B, fluconazole, and voriconazole ranged from 0.25 to >16 μg ml−1, 0.5–8 μg ml−1, and 0.01–0.25 μg ml−1, respectively. We investigated biofilm formation by the isolates, and no biofilm production was found in one isolate, low biofilm production in forty-four isolates, and medium biofilm production in six isolates. T. inkin produced biofilms at low levels, and Trichosporon spp. produced biofilms at medium levels. This research increases our understanding of the molecular epidemiology of Trichosporon spp. isolated from one university hospital in Bangkok, Thailand, and reveals their genetic diversity, antifungal susceptibility profiles, and capacity for in vitro biofilm production.
-
1.
Colombo AL, Padovan ACB, Chaves GM. Current knowledge of Trichosporon spp. and trichosporonosis. Clin Microbiol Rev 2011; 24(4): 682–700.
-
2.
Sugita T, Nishikawa A, Ichikawa T, Ikeda R, Shinoda T. Isolation of Trichosporon asahii from environmental materials. Med Mycol 2000; 38(1): 27–30.
-
3.
Ma X, Jiang Y, Wang C, Gu Y, Cao S, Huang X, et al. Identification, genotyping, and pathogenicity of Trichosporon spp. isolated from giant pandas (Ailuropoda melanoleuca). BMC Microbiol 2019; 19(1): 113.
-
4.
Ramírez I, Moncada DC. Fatal disseminated infection by Trichosporon asahii under voriconazole therapy in a patient with acute myeloid leukemia: a review of breakthrough infections by Trichosporon spp. Mycopathologia 2019; 185: 377–388.
-
5.
Montoya AM, González GM. Trichosporon spp. an emerging fungal pathogen. Medicina Universitaria 2014; 16(62): 37–43.
-
6.
Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D'Antonio D, Piccolomini R. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother 2006; 50(10): 3269–3276.
-
7.
Iturrieta-Gonzalez Isabel Antonieta PACB, Bizerra Fernando Cesar, Hahn Rosane Christine, Colombo Arnaldo Lopes. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. Plos One 2014; 9(10): e109553.
-
8.
Aydin M, Kustimur S, Kalkanci A, Duran T. Identification of medically important yeasts by sequence analysis of the internal transcribed spacer and D1/D2 region of the large ribosomal subunit. Revista iberoamericana de micologia 2019; 36(3): 129–138.
-
9.
Kalkanci A, Sugita T, Arikan S, Yucesoy M, Ener B, Otag F, et al. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol 2010; 48(1): 141–146.
-
10.
Chagas-Neto TC, Chaves GM, Melo ASA, Colombo AL. Bloodstream infections due to Trichosporon spp: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009; 47: 1074–1081.
-
11.
Nobrega de Almeida J, Jr., Moreno L, Francisco EC, Noronha Marques G, Mendes AV, Barberino MG, et al. Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids. Mycoses 2021; 64(8): 817–822.
-
12.
Sun W, Su J, Xu S, Yan D. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing. J Med Microbiol 2012; 61(Pt 12): 1750–1757.
-
13.
Wongsuk T, Homkaew A, Faksri K, Thongnak C. Multi-locus sequence typing and whole genome sequence analysis of Cryptococcus neoformans isolated from clinical specimens in Vajira Hospital, Bangkok, Thailand. Mycopathologia 2020; 185(3): 503–514.
-
14.
Sellami H, Trabelsi H, Neji S, Amouri I, Cheikhrouhou F, Makni F, et al. First genotype identification of Trichosporon asahii in Sfax, Tunisia. J Med Microbiol 2017; 66(4): 397–401.
-
15.
Sugita T, Nishikawa A, Shinoda T. Rapid detection of species of the opportunistic yeast Trichosporon by PCR. J Clin Microbiol 1998; 36(5): 1458–1460.
-
16.
Sugita T, Nakajima M, Ikeda R, Matsushima T, Shinoda T. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 2002; 40(5): 1826–1830.
-
17.
NCBI Resource Coordinators. Database resources of the national center for biotechnology information. Nucleic Acids Res 2016; 44(D1): D7–D19. https://doi.org/10.1093/nar/gkv1290.
-
18.
Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol 2021; 38(7): 3022–3027.
-
19.
Rex Ja, B, Andres, D, Arthinton-Skaggs, B, Brown, S, Chaurvedi, V, Ghannoum, M, et al. Clinical and laboratory standards Institute: M27-A3 reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard—third edition; CLSI: Wayne, NJ, USA. 2008.
-
20.
Procop Gd, P, Berkow, E, Fuller, J, Hanson, K, Holliday, N, Pincus, D, et al. Clinical and laboratory standards institute:M60-ED 1: performance standards for antifungal susceptibility testing of yeasts; CLSI: Wayne, NJ, USA. 2017.
-
21.
Bobrek K, Sokol I, Gawel A. Uncommon non-candida yeasts in healthy Turkeys-antimicrobial susceptibility and biochemical characteristic of Trichosporon isolates. Pathogens 2021; 10(5).
-
22.
Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, et al. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. Clin Microbiol Infect 2019; 25(7): 909 e1–e5.
-
23.
Khan SN, Khan S, Iqbal J, Khan R, Khan AU. Enhanced killing and antibiofilm activity of encapsulated cinnamaldehyde against Candida albicans. Front Microbiol 2017; 8: 1641.
-
24.
Iturrieta-Gonzalez IA, Padovan AC, Bizerra FC, Hahn RC, Colombo AL. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B. PLoS One 2014; 9(10): e109553.
-
25.
Kurakado S, Miyashita T, Chiba R, Sato C, Matsumoto Y, Sugita T. Role of arthroconidia in biofilm formation by Trichosporon asahii. Mycoses 2021; 64(1): 42–47.
-
26.
do Espirito Santo EPT, Monteiro RC, da Costa ARF, Marques-da-Silva SH. Molecular Identification, Genotyping, phenotyping, and antifungal susceptibilities of medically important Trichosporon, Apiotrichum, and Cutaneotrichosporon species. Mycopathologia 2020; 185(2): 307–317.
-
27.
Sugita T, Ikeda R, Nishikawa A. Analysis of Trichosporon isolates obtained from the houses of patients with summer-type hypersensitivity pneumonitis. J Clin Microbiol 2004; 42(12): 5467–5471.
-
28.
Rodriguez-Tudela JL, Gomez-Lopez A, Alastruey-Izquierdo A, Mellado E, Bernal-Martinez L, Cuenca-Estrella M. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 2007; 58(4): 435–440.
-
29.
Almeida AA, Crispim Bdo A, Grisolia AB, Svidzinski TI, Ortolani LG, Oliveira KM. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients. Rev Argent Microbiol 2016; 48(1): 62–66.
-
30.
Xia Z, Yang R, Wang W, Cong L. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients. Mycopathologia 2012; 173(2–3): 127–133.
-
31.
Ribeiro MA, Ngamskulrungroj P. Molecular characterization of environmental Cryptococcus neoformans isolated in Vitoria, ES, Brazil. Rev Inst Med Trop Sao Paulo 2008; 50(6): 315–320.
-
32.
Kalkanci A, Sugita T, Arikan S, Yucesoy M, Ener B, Otag F, et al. Molecular identification, genotyping, and drug susceptibility of the basidiomycetous yeast pathogen Trichosporon isolated from Turkish patients. Med Mycol 2010; 48(1): 141–146.
-
33.
Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16(2): 111–120.
-
34.
Mekha N, Sugita T, Ikeda R, Nishikawa A, Autthateinchai R, Poonwan N, et al. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients. Mycopathologia 2010; 169(1): 67–70.
-
35.
Ali GA, Husain A, Salah H, Goravey W. Trichosporon asahii fungemia and COVID-19 co-infection: an emerging fungal pathogen; case report and review of the literature. IDCases 2021; 25: e01244.
-
36.
Samaddar A, Diwakar J, Krishnan P, Veena Kumari HB, Kavya M, Konar S, et al. COVID-19-associated brain abscess caused by Trichosporon dohaense: a case report and review of literature. Med Mycol Case Rep 2022; 35: 9–14.
-
37.
Segrelles-Calvo G, Araujo GRS, Llopis-Pastor E, Frases S. Trichosporon asahii as cause of nosocomial pneumonia in patient with COVID-19: a triple co-infection. Arch Bronconeumol 2021; 57: 46–48.
-
38.
Cronyn V, Howard J, Chiang L, Le L, Tims-Cook Z, Gertz AM. Trichosporon asahii urinary tract infection in a patient with severe COVID-19. Case Rep Infect Dis 2021; 2021: 6841393.
-
39.
Anunnatsiri S, Chetchotisakd P, Mootsikapun P. Fungemia in non-HIV-infected patients: a five-year review. Int J Infect Dis 2009; 13(1): 90–96.
-
40.
Issarachaikul R, Lertwannawit O, Detporntewan P, Uaprasert N, Plongla R, Shuangshoti S, et al. Catheter-related bloodstream infections caused by Trichosporon species. Southeast Asian J Trop Med Public Health 2014; 45(2): 421–429.
-
41.
Takashima M, Sugita T. Draft genome analysis of Trichosporonales species that contribute to the taxonomy of the genus Trichosporon and related taxa. Med Mycol J 2019; 60(2): 51–57.
-
42.
Liu XZ, Wang QM, Goker M, Groenewald M, Kachalkin AV, Lumbsch HT, et al. Towards an integrated phylogenetic classification of the Tremellomycetes. Stud Mycol 2015; 81: 85–147.
-
43.
Liu XZ, Wang QM, Theelen B, Groenewald M, Bai FY, Boekhout T. Phylogeny of tremellomycetous yeasts and related dimorphic and filamentous basidiomycetes reconstructed from multiple gene sequence analyses. Stud Mycol 2015; 81: 1–26.
-
44.
Martinez-Herrera E, Duarte-Escalante E, Reyes-Montes MDR, Arenas R, Acosta-Altamirano G, Moreno-Coutino G, et al. Molecular identification of yeasts from the order Trichosporonales causing superficial infections. Rev Iberoam Micol 2021; 38(3): 119–124.
-
45.
Francisco EC, de Almeida Junior JN, Queiroz-Telles F, Aquino VR, Mendes AVA, de Oliveira Silva M, et al. Correlation of Trichosporon asahii genotypes with anatomical sites and antifungal susceptibility profiles: data analyses from 284 isolates collected in the last 22 years across 24 medical centers. Antimicrob Agents Chemother 2021; 65(3).
-
46.
Guo LN, Yu SY, Hsueh PR, Al-Hatmi AMS, Meis JF, Hagen F, et al. Invasive infections due to Trichosporon: species distribution, genotyping, and antifungal susceptibilities from a multicenter study in China. J Clin Microbiol 2019; 57(2).
-
47.
Dabas Y, Xess I, Kale P. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen. Med Mycol 2017; 55(5): 518–527.
-
48.
Desnos-Ollivier M, Maufrais C, Pihet M, Aznar C, Dromer F, French Mycoses Study G. Epidemiological investigation for grouped cases of Trichosporon asahii using whole genome and IGS1 sequencing. Mycoses 2020; 63(9): 942–951.
-
49.
Montoya AM, Sanchez Gonzalez A, Palma-Nicolas JP, Gomez-Trevino A, Gonzalez JG, Gonzalez GM. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients. Med Mycol 2015; 53(5): 505–511.
-
50.
Kuo SH, Lu PL, Chen YC, Ho MW, Lee CH, Chou CH, et al. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients. J Formos Med Assoc 2021; 120(9): 1686–1694.
-
51.
Hazirolan G, Kocak N, Karagoz A. Sequence-based identification, genotyping and virulence factors of Trichosporon asahii strains isolated from urine samples of hospitalized patients (2011–2016). J Mycol Med 2018; 28(3): 452–456.
-
52.
Arastehfar A, de Almeida Junior JN, Perlin DS, Ilkit M, Boekhout T, Colombo AL. Multidrug-resistant Trichosporon species: underestimated fungal pathogens posing imminent threats in clinical settings. Crit Rev Microbiol 2021; 47(6): 679–698.
-
53.
Rastogi V, Honnavar P, Rudramurthy SM, Pamidi U, Ghosh A, Chakrabarti A. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India. Mycoses 2016; 59(8): 528–534.
-
54.
Cordeiro RA, Aguiar ALR, da Silva BN, Pereira LMG, Portela FVM, de Camargo ZP, et al. Trichosporon asahii and Trichosporon inkin biofilms produce antifungal-tolerant persister cells. Front Cel Infect Microbiol 2021; 11: 645812.
-
55.
Nobrega de Almeida J, Francisco EC, Holguin Ruiz A, Cuellar LE, Rodrigues Aquino V, Verena Mendes A, et al. Epidemiology, clinical aspects, outcomes and prognostic factors associated with Trichosporon fungaemia: results of an international multicentre study carried out at 23 medical centres. J Antimicrob Chemother. 2021; 76(7): 1907–1915.
-
56.
Khan ID, Sahni AK, Basu A, Haleem S. Trichosporon asahii urinary tract infection in immunocompetent patients. Med J Armed Forces India. 2015; 71(4): 373–376.
Please, download the file from HERE
Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary
Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- Chemical Abstracts
- Global Health
- Index Medicus
- Index Veterinarius
- Medline
- Referativnyi Zhurnal
- SCOPUS
- Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 1.3 |
| Rank by Impact Factor | Q4 (Immunology) |
| Journal Citation Indicator | 0.31 |
| Scopus | |
| CiteScore | 2.3 |
| CiteScore rank | Q3 (Infectious Diseases) |
| SNIP | 0.389 |
| Scimago | |
| SJR index | 0.308 |
| SJR Q rank | Q3 |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article (only for OA publications) |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 772 EUR / 848 USD Print + online subscription: 860 EUR / 944 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Language | English |
| Size | A4 |
| Year of Foundation |
1954 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 1217-8950 (Print) |
| ISSN | 1588-2640 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Mar 2024 | 86 | 3 | 3 |
| Apr 2024 | 36 | 1 | 2 |
| May 2024 | 36 | 1 | 1 |
| Jun 2024 | 51 | 1 | 3 |
| Jul 2024 | 64 | 0 | 0 |
| Aug 2024 | 67 | 2 | 2 |
| Sep 2024 | 22 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.